TSC SWOT

From HL7 TSC
Revision as of 14:33, 3 October 2015 by Anne wizauer (talk | contribs)
Jump to navigation Jump to search
  • Strengths
    • Clear focus on delineated governance and management activities
    • Respected, committed, highly experienced membership
    • Support from HQ
    • Open, transparent, and responsive
    • Proactive
  • Weaknesses
    • Limited time
    • Limited control over resources
    • Inconsistent support from Board and Working Groups
    • Lack of effective process for bringing in external proposed standards.
    • Lack of clear definition of the endorsement of external standards
    • Lack of linkage with HL7 Strategic Plan
  • Opportunities
    • Business Architecture Model development offers improved Governance and Management to match existing Methodology strengths
    • Change to Intellectual Property licensing at no cost
    • Increased worldwide uptake (by transnational/regional programs)
    • Clearly designate our product line and product identification
    • Emergence of new and contemporary technology including FHIR and semantic web ontologies
    • Respond to new opportunities for increasing membership
    • Provide mechanisms to allow vitality assessment throughout the organization
  • Threats
    • Creating overheads without visible return
    • Improve Product Quality
    • Lack of confidence in standards management creates vacuum for Profiler/Enforcer creating their own healthcare interoperability standards
    • Increasing numbers of mandates coming from the US Realm
    • Lack of clear governance surrounding new member benefits e.g. user groups, help desk
    • Keeping up with increased uptake of our standards (e.g. FHIR)
    • Lack of adequate governance, management, curation and support processes to manage our standards and the resulting profiles that are created.
    • Change to intellectual property licensing has created the need to adjust organizational processes to manage the impact of that change.

Approved by TSC 2014-09-13